caffeic acid and Neuroblastoma

caffeic acid has been researched along with Neuroblastoma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Diao, A; Guo, B; Guo, Z; Hao, L; Li, L; Li, Y; Liu, Z; Yang, Y; Zhao, Q1
Alza, NP; Murray, AP; Salvador, GA1
Gunjima, K; Hashida, K; Hori, O; Konishi, T; Matsugo, S; Nakamura, Y; Takakura, K; Tomiyama, R; Yamada, T1
David, P; Naidu, M; Phan, CW; Sabaratnam, V; Wong, KH1
Chlapek, P; Hermanova, M; Loja, T; Redova, M; Sterba, J; Veselska, R; Zitterbart, K1
Chlapek, P; Hermanova, M; Redova, M; Sterba, J; Veselska, R; Zitterbart, K1

Other Studies

6 other study(ies) available for caffeic acid and Neuroblastoma

ArticleYear
The novel prolyl hydroxylase-2 inhibitor caffeic acid upregulates hypoxia inducible factor and protects against hypoxia.
    European journal of pharmacology, 2022, Nov-05, Volume: 934

    Topics: Animals; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Lactate Dehydrogenases; Lactic Acid; Malondialdehyde; Mice; Neuroblastoma; Neuroprotective Agents; Procollagen-Proline Dioxygenase; Prolyl-Hydroxylase Inhibitors; RNA, Messenger; Transcription Factors; Vascular Endothelial Growth Factor A

2022
Cativic acid-caffeic acid hybrid exerts cytotoxic effects and induces apoptotic death in human neuroblastoma cells.
    Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caffeic Acids; Caspase 3; Cell Cycle; Cell Line, Tumor; Diterpenes; Grindelia; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neuroblastoma; Nuclear Localization Signals

2017
3,4-dihydroxybenzalacetone protects against Parkinson's disease-related neurotoxin 6-OHDA through Akt/Nrf2/glutathione pathway.
    Journal of cellular biochemistry, 2014, Volume: 115, Issue:1

    Topics: Buthionine Sulfoximine; Caffeic Acids; Cell Line, Tumor; Dose-Response Relationship, Drug; Glutathione; Humans; Neuroblastoma; Neuroprotective Agents; Neurotoxins; NF-E2-Related Factor 2; Oxidative Stress; Oxidopamine; Parkinson Disease; Protein Transport; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species

2014
Uridine from Pleurotus giganteus and Its Neurite Outgrowth Stimulatory Effects with Underlying Mechanism.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Animals; Benzoic Acid; Biomarkers; Caffeic Acids; Cell Line, Tumor; Cinnamates; Coumaric Acids; Cyclic AMP Response Element-Binding Protein; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; GAP-43 Protein; Linoleic Acid; MAP Kinase Signaling System; Mice; Neurites; Neuroblastoma; Oleic Acid; Phosphorylation; Pleurotus; Propionates; Proto-Oncogene Proteins c-akt; Signal Transduction; Succinic Acid; Uridine

2015
Influence of LOX/COX inhibitors on cell differentiation induced by all-trans retinoic acid in neuroblastoma cell lines.
    International journal of molecular medicine, 2010, Volume: 25, Issue:2

    Topics: Apoptosis; Caffeic Acids; Celecoxib; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Shape; Cyclooxygenase 2 Inhibitors; Flow Cytometry; Humans; Lipoxygenase Inhibitors; Neuroblastoma; Pyrazoles; Sulfonamides; Tretinoin

2010
Enhancement of ATRA-induced differentiation of neuroblastoma cells with LOX/COX inhibitors: an expression profiling study.
    Journal of experimental & clinical cancer research : CR, 2010, May-11, Volume: 29

    Topics: Brain Neoplasms; Caffeic Acids; Celecoxib; Cell Differentiation; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lipoxygenase Inhibitors; Multigene Family; Neuroblastoma; Oxidative Stress; Pyrazoles; Sulfonamides; Tretinoin

2010